LINE-1 methylation shows little intra-patient heterogeneity in primary and synchronous metastatic colorectal cancer

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Matsunoki, Aika ^a,b   Kawakami, Kazuyuki ^a   Kotake, Masanori ^a,b   Kaneko, Mami ^a,b   Kitamura, Hirotaka ^a,b   Ooi, Akishi ^b   Watanabe, Go ^b   Minamoto, Toshinari ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Colorectal cancer; DNA methylation; Laser microdissection; LINE 1

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DNA ISOLATION; DNA METHYLATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG INTERSPERSED REPEAT; LYMPH NODE METASTASIS; MALE; METASTATIC COLORECTAL CANCER; MUCOSA CELL; STROMA CELL; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; HUMANS; LASER CAPTURE MICRODISSECTION; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84870331923     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-574     Document Type: Article

References (29)

1. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983, 301:89-92. 10.1038/301089a0, 6185846.
2. Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985, 228:187-190. 10.1126/science.2579435, 2579435.
3. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002, 21:5400-5413. 10.1038/sj.onc.1205651, 12154403.
4. Symer DE, Connelly C, Szak ST, Caputo EM, Cost GJ, Parmigiani G, Boeke JD. Human l1 retrotransposition is associated with genetic instability in vivo. Cell 2002, 110:327-338. 10.1016/S0092-8674(02)00839-5, 12176320.
5. Schulz WA. L1 retrotransposons in human cancers. J Biomed Biotechnol 2006, 2006:83672. 1559935, 16877821.
6. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921. 10.1038/35057062, 11237011.
7. Deininger PL, Moran JV, Batzer MA, Kazazian HH. Mobile elements and mammalian genome evolution. Curr Opin Genet Dev 2003, 13:651-658. 10.1016/j.gde.2003.10.013, 14638329.
8. Kazazian HH. Mobile elements: drivers of genome evolution. Science 2004, 303:1626-1632. 10.1126/science.1089670, 15016989.
9. Sassaman DM, Dombroski BA, Moran JV, Kimberland ML, Naas TP, DeBerardinis RJ, Gabriel A, Swergold GD, Kazazian HH. Many human L1 elements are capable of retrotransposition. Nat Genet 1997, 16:37-43. 10.1038/ng0597-37, 9140393.
10. Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, Kazazian HH. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci USA 2003, 100:5280-5285. 10.1073/pnas.0831042100, 154336, 12682288.
11. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004, 32:e38. 10.1093/nar/gnh032, 373427, 14973332.
12. Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet 2010, 6:e1000917. 10.1371/journal.pgen.1000917, 2858672, 20421991.
13. Sunami E, de Maat M, Vu A, Turner RR, Hoon DS. LINE-1 hypomethylation during primary colon cancer progression. PLoS One 2011, 6:e18884. 10.1371/journal.pone.0018884, 3077413, 21533144.
14. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 2008, 100:1734-1738. 10.1093/jnci/djn359, 2639290, 19033568.
15. Kawakami K, Matsunoki A, Kaneko M, Saito K, Watanabe G, Minamoto T. Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer. Cancer Sci 2011, 102:166-174. 10.1111/j.1349-7006.2010.01776.x, 21087350.
16. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000, 28:E32. 10.1093/nar/28.8.e32, 102836, 10734209.
17. R Development Core Team R: A language and environment for statistical computing 2008, Vienna/Austria: R Foundation for Statistical Computing, R Development Core Team.
18. Iacopetta B, Grieu F, Phillips M, Ruszkiewicz A, Moore J, Minamoto T, Kawakami K. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa. Cancer Sci 2007, 98:1454-1460. 10.1111/j.1349-7006.2007.00548.x, 17640302.
19. Estecio MR, Gharibyan V, Shen L, Ibrahim AE, Doshi K, He R, Jelinek J, Yang AS, Yan PS, Huang TH, Tajara EH, Issa JP. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2007, 2:e399. 10.1371/journal.pone.0000399, 1851990, 17476321.
20. Ogino S, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer 2008, 122:2767-2773. 10.1002/ijc.23470, 2630175, 18366060.
21. van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, Iacopetta B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 2002, 51:797-802. 10.1136/gut.51.6.797, 1773491, 12427779.
22. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, Wolff RK, Slattery ML. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005, 129:837-845. 10.1053/j.gastro.2005.06.020, 16143123.
23. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Castillejo JA, Navarro G, San Jose-Eneriz E, Garate L, Cordeu L, Cervantes F, Prosper F, Heiniger A, Torres A. Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia. Leuk Res 2008, 32:487-490. 10.1016/j.leukres.2007.07.021, 17765966.
24. Saito K, Kawakami K, Matsumoto I, Oda M, Watanabe G, Minamoto T. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer. Clin Cancer Res 2010, 16:2418-2426. 10.1158/1078-0432.CCR-09-2819, 20371677.
25. Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR, Wu TT. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 2003, 162:815-822. 10.1016/S0002-9440(10)63878-3, 1868094, 12598316.
26. Jass JR. Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2005, 2:398-405.
27. Losi L, Baisse B, Bouzourene H, Benhattar J. Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis 2005, 26:916-922.
28. Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin Cancer Res 2010, 16:790-799. 10.1158/1078-0432.CCR-09-2446, 20103678.
29. Yoshida T, Yamashita S, Takamura-Enya T, Niwa T, Ando T, Enomoto S, Maekita T, Nakazawa K, Tatematsu M, Ichinose M, Ushijima T. Alu and Satalpha hypomethylation in Helicobacter pylori-infected gastric mucosae. Int J Cancer 2011, 128:33-39. 10.1002/ijc.25534, 20602342.